NEUROCRINE BIOSCIENCES INC Insider Trading for July 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEUROCRINE BIOSCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEUROCRINE BIOSCIENCES INC for July 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 31 2019 | NBIX | NEUROCRINE BIOSCIE ... | LYONS GARY A | Director | Sell | S | 92.07 | 10,000 | 920,686 | 235,697 | 245.7 K to 235.7 K (-4.07 %) |
| Jul 31 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Option Exercise | M | 18.15 | 15,831 | 287,333 | 0 | |
| Jul 31 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Sell | S | 92.13 | 15,831 | 1,458,569 | 19,961 | 35.8 K to 20 K (-44.23 %) |
| Jul 31 2019 | NBIX | NEUROCRINE BIOSCIE ... | Lippoldt Darin | Chief Legal Officer | Buy | M | 18.15 | 15,831 | 287,333 | 35,792 | 20 K to 35.8 K (+79.31 %) |
| Jul 31 2019 | NBIX | NEUROCRINE BIOSCIE ... | Grigoriadis Dimitri E. | Chief Research Offi ... | Option Exercise | M | 32.99 | 50,000 | 1,649,500 | 10,188 | |
| Jul 31 2019 | NBIX | NEUROCRINE BIOSCIE ... | Grigoriadis Dimitri E. | Chief Research Offi ... | Sell | S | 94.31 | 10,000 | 943,118 | 108,408 | 118.4 K to 108.4 K (-8.45 %) |
| Jul 31 2019 | NBIX | NEUROCRINE BIOSCIE ... | Grigoriadis Dimitri E. | Chief Research Offi ... | Sell | S | 92.65 | 50,000 | 4,632,320 | 118,408 | 168.4 K to 118.4 K (-29.69 %) |
| Jul 31 2019 | NBIX | NEUROCRINE BIOSCIE ... | Grigoriadis Dimitri E. | Chief Research Offi ... | Buy | M | 32.99 | 50,000 | 1,649,500 | 168,408 | 118.4 K to 168.4 K (+42.23 %) |
| Jul 31 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 43.24 | 25,600 | 1,106,944 | 33,860 | |
| Jul 31 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 32.99 | 18,756 | 618,760 | 0 | |
| Jul 31 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 93.52 | 25,600 | 2,394,227 | 141,976 | 167.6 K to 142 K (-15.28 %) |
| Jul 31 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 43.24 | 25,600 | 1,106,944 | 167,576 | 142 K to 167.6 K (+18.03 %) |
| Jul 31 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 91.74 | 18,756 | 1,720,630 | 141,976 | 160.7 K to 142 K (-11.67 %) |
| Jul 31 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 32.99 | 18,756 | 618,760 | 160,732 | 142 K to 160.7 K (+13.21 %) |
| Jul 17 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 32.99 | 30,680 | 1,012,133 | 18,756 | |
| Jul 17 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 87.50 | 30,680 | 2,684,506 | 141,976 | 172.7 K to 142 K (-17.77 %) |
| Jul 17 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 32.99 | 30,680 | 1,012,133 | 172,656 | 142 K to 172.7 K (+21.61 %) |
| Jul 17 2019 | NBIX | NEUROCRINE BIOSCIE ... | BENEVICH ERIC | Chief Commercial Of ... | Sell | S | 87.44 | 5,835 | 510,201 | 14,910 | 20.7 K to 14.9 K (-28.13 %) |
| Jul 12 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 32.99 | 100 | 3,299 | 49,436 | |
| Jul 12 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Option Exercise | M | 32.99 | 7,120 | 234,889 | 49,536 | |
| Jul 12 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 87.59 | 100 | 8,759 | 141,976 | 142.1 K to 142 K (-0.07 %) |
| Jul 12 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 32.99 | 100 | 3,299 | 142,076 | 142 K to 142.1 K (+0.07 %) |
| Jul 12 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Sell | S | 87.63 | 7,120 | 623,958 | 141,976 | 149.1 K to 142 K (-4.78 %) |
| Jul 12 2019 | NBIX | NEUROCRINE BIOSCIE ... | Bozigian Haig P. | Chief Development O ... | Buy | M | 32.99 | 7,120 | 234,889 | 149,096 | 142 K to 149.1 K (+5.01 %) |